iRhythm Technologies, Inc.

Profile narrative

iRhythm Technologies, Inc. provides ambulatory cardiac monitoring solutions that combine wearable sensor technology with automated data analysis and reporting services for the detection of heart rhythm abnormalities. Its flagship product, the Zio XT patch, is a single‑use, water‑resistant adhesive device that can be worn for up to 14 days to continuously record electrocardiographic signals. The company also offers shorter‑term monitoring options such as the Zio AT patch and supplies the collected data to a CLIA‑certified laboratory where proprietary algorithms identify arrhythmias including atrial fibrillation, bradycardia and tachycardia. Physicians receive structured reports that summarize the findings, enabling timely clinical decision‑making. iRhythm serves healthcare providers, clinics and health systems primarily within the United States, delivering its monitoring service through a direct‑to‑provider model that includes device shipment, data transmission and analysis.

The firm distinguishes itself through a specialization in long‑term, continuous outpatient monitoring that aims to increase diagnostic yield compared with traditional short‑term Holter studies. Its Zio patch platform utilizes a proprietary silicone‑based adhesive and signal‑processing technology designed to minimize motion artifacts and maintain signal fidelity during normal patient activities. iRhythm’s analytics engine incorporates machine‑learning techniques that have been validated in clinical studies and cleared by the U.S. Food and Drug Administration for arrhythmia detection. The company maintains an end‑to‑end service approach, owning the device logistics, the analytical laboratory and the reporting workflow, which reduces reliance on third‑party vendors for critical steps. This vertical integration supports consistent quality control and allows rapid iteration of both hardware and software components based on real‑world performance data.

Structurally, iRhythm Technologies, Inc. is an independent, publicly traded corporation listed on the NASDAQ under the ticker symbol IRTC and is incorporated in the State of Delaware. The company’s headquarters are located in the United States, as indicated in the organisational context. In June 2026 iRhythm disclosed a security incident in which unauthorized activity was detected on certain third‑party‑hosted business applications; the breach was identified after a threat actor claimed to have exfiltrated proprietary information, patient protected health data and other personal details and demanded payment. The company confirmed that some data had been removed from the applications but noted that its clinical or medical device systems, manufacturing, distribution, patient safety and financial reporting systems remained unaffected and that there was no evidence of ongoing unauthorized access at the time of disclosure. iRhythm stated that it was working with external cybersecurity experts and maintained cybersecurity insurance coverage while assessing the potential impact of the event.

Incidents

1 incident linked to this organisation.